Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine

Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine

Abstract Background It has been estimated that approximately 15% of people who are incarcerated in the US have histories of opioid use disorder. Relapse to opioid use after release from prison poses a serious risk of HIV infection. Prison-initiated buprenorphine may help to reduce HIV infection give...

Full description

Bibliographic Details
Main Authors: Thomas R. Blue, Michael S. Gordon, Robert P. Schwartz, Kathryn Couvillion, Frank J. Vocci, Terrence T. Fitzgerald, Kevin E. O’Grady
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Addiction Science & Clinical Practice
Subjects:
Hiv-risk behavior
Buprenorphine
Prison
Opioid use disorder
Correctional settings
Online Access:https://doi.org/10.1186/s13722-019-0172-2

Internet

https://doi.org/10.1186/s13722-019-0172-2

Similar Items